Published in Drug Week, March 20th, 2009
"Choroidal neovascularization (CNV) occurs in 15% of VKH patients and is associated with poor visual prognosis. We report on two patients with VKH syndrome and CNV that were treated with intravitreal bevacizumab. One of the VKH patients also had an extrafoveal CNV membrane and underwent multiple intravitreal injections of bevacizumab in combination with laser photocoagulation, with subsequent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.